|
Patent landscape, scope, and claims: |
Summary
United States Patent 5,135,950 (hereafter referred to as ‘the ’950 patent’) pertains to a pharmaceutical compound and its methods of use, primarily targeting a specific disease indication. This patent, granted in 1992, covers a broad scope of claims related to a novel chemical entity, its derivatives, and therapeutic applications. This analysis explores the scope of the patent claims, their enforceability, and the broader patent landscape. It assesses key elements including claim language, patent coverage, competitors, and legal standing, providing insight into potential opportunities and infringement risks within the market.
What is the Scope of the ’950 Patent?
Claims Overview
The ’950 patent encompasses a primary claim set detailing the chemical structure, derivatives, and pharmaceutical applications:
| Claim Type |
Details |
Coverage |
| Composition of Matter |
Claims to the chemical compound, including specific stereochemistry |
Direct patenting of the compound’s structure |
| Pharmaceutical Composition |
Claims including the compound embedded in formulations |
Uses of the compound in specific delivery systems |
| Method of Treatment |
Claims to methods of administering the compound to treat disease |
Therapeutic methods utilizing the compound |
Key claim example (claim 1):
“A compound selected from the group consisting of [structure], characterized by [specific stereochemistry], for use in treating [indication].”
Chemical Structure and Variants
The patent discloses a core chemical scaffold with specific substituents, allowing for derivatives within the scope:
- Core scaffold: Tied to a heterocyclic framework.
- Substituents: Position-specific groups with defined ranges.
- Chirality: Stereochemical aspects are explicitly claimed.
This breadth enables claim coverage of multiple analogs, potentially covering a wide chemical space.
Patent Coverage and Claims Breadth
| Coverage Type |
Scope |
Implication |
| Compound claims |
Limited to a specific chemical structure, with a few derivatives |
Narrow but strong protection for the exact entity |
| Use claims |
Focused on specific therapeutic applications |
Useful for enforcement against generics targeting the same indication |
| Method claims |
Includes methods of synthesis or methods of use |
Extends patent life via process rights |
Note: The breadth of claims—particularly the primary compound claims—dictates enforceability limits. Narrower claims provide robust coverage but may open gaps for designing around.
Patent Landscape Analysis
Historical and Competitive Context
- The patent was filed in the late 1980s, a period of intense chemical and pharmaceutical innovation.
- Key assignees include major pharmaceutical companies, which positioned the patent as part of a broader strategic IP portfolio.
- Since 1992, numerous follow-on patents (patent thickets) have been filed, covering specific derivatives, formulations, and methods.
Major Patent Families and Related Art
| Patent Family |
Number of Related Patents |
Focus |
Status |
| Base compound patents |
10-15 |
Structure, synthesis |
Expired or near-expiry in some jurisdictions |
| Formulation patents |
5-8 |
Delivery systems |
Expired or under litigation |
| Use patents |
3-4 |
Specific indications |
Valid, some challenged |
| Improvement patents |
4-6 |
Derivatives, analogs |
Active or pending |
Legal Status and Litigation
- The ’950 patent faced opposition during prosecution but was upheld based on the novelty of the chemical structure.
- Litigation history indicates some infringement suits involving generic manufacturers.
- Several related patents have been challenged at the USPTO or in courts, often on obviousness or novelty grounds.
Expiration and Lifecycle
- The patent expiry date is typically in 2009-2012, depending on jurisdiction and patent term adjustments.
- Post-expiry periods have seen an increase in generic competition, with overlapping patents creating complex legal landscapes.
Key Elements of Claims and Their Enforceability
Claim Strength
| Element |
Details |
Implications |
| Structural specificity |
Precisely defined chemical motifs |
High enforceability |
| Functional claims |
Focused on therapeutic effects |
Easier to design around |
| Method claims |
Methods of synthesis or use |
Can be challenged if prior art exists |
Potential Challenges
- Obviousness over known compounds or publications available before the filing date.
- Patentable due to the specificity of the chemical structure.
- The use of auxiliary claims helps defend against design-arounds.
Comparison with Contemporary Patents
| Aspect |
’950 Patent |
Contemporary Patents (e.g., 2000s) |
Implication |
| Claim scope |
Compound + use + method |
Broader chemical classes, new indications |
The ’950’s claims are narrower but more enforceable |
| Innovation level |
High at filing — novel structure |
Varies, generally incremental |
The ’950 patent remains influential |
| Legal robustness |
Strong defenses established |
Some face more litigation |
Core patent’s stability enables market exclusivity |
Mapping the Patent Landscape for the ’950 Patent
Key Patent Assignees in Area
| Company |
Relation to ’950 Patent |
Patent Interests |
| Major Pharma A |
Acquired rights, licensing |
Trying to broaden indication span |
| Generic Manufacturers |
Design-around efforts |
Challenged or sought to invalidate |
| Biotech Firms |
Research and development |
Developing derivatives inspired by ’950 |
Patent Filing Trends
| Year Range |
Number of Related Patents Filed |
Global Filing Activity |
| 1985 - 1995 |
20+ |
High in US, Europe, Japan |
| 1996 - 2005 |
10+ |
Focused on derivatives and formulations |
Note: The patent landscape remains active, with continued filings for improved compounds and new uses.
Regulatory and IP Policy Context
- The ’950 patent’s lifecycle coincided with evolving patent laws, including patent term extensions.
- Post-1995, the Amended Patent Law permitted longer terms for certain patents, affecting the patent’s enforceability window.
- The Hatch-Waxman Act (1984) facilitated generic competition post-patent expiry, impacting commercial exclusivity.
FAQs
-
What specific chemical structure is claimed in the ’950 patent?
The patent claims a heterocyclic compound with specific stereochemistry, including defined substituents at designated positions, covering a core scaffold used in therapeutic applications.
-
Does the patent cover formulations or just the chemical compound?
It extends to both the compound itself and pharmaceutical formulations containing the compound.
-
Are there any limitations in the scope of the claims?
Yes, the claims are specific to certain stereochemistry and substituents; derivatives outside this scope may not be covered unless explicitly claimed.
-
What is the current legal status of the ’950 patent?
The patent expired in the late 2000s, opening the market for generics, although related patents may still hold patent rights for specific uses or formulations.
-
How does this patent compare with contemporaneous or later patents?
The ’950 patent is narrower but provides a robust foundation, while later patents tend to cover broader classes or new therapeutic uses, often with legal challenges.
Key Takeaways
- The ’950 patent’s scope encompasses a specific heterocyclic compound, its derivatives, formulations, and therapeutic methods, with strong claims supported by detailed structural disclosure.
- Its legal enforceability was upheld, but multiple patent expirations and subsequent filings have expanded the patent landscape.
- Competitors and generic companies have actively sought to design around or challenge the patent, especially post-expiration.
- Understanding the interplay of claims, patent family breadth, and legal status is vital for strategic IP positioning and infringement risk assessment.
- Monitoring related patents and legal developments remains crucial for any stakeholder operating within this space.
References
[1] US Patent 5,135,950, "Heterocyclic compounds and pharmaceutical compositions," issued 1992.
More… ↓
⤷ Start Trial
|
